Literature DB >> 8711445

Osteotomy of the first metacarpal for osteoarthrosis of the basal joints of the thumb.

J Holmberg1, G Lundborg.   

Abstract

A radial, 30 degrees wedge osteotomy was used for treatment of osteoarthrosis of the trapeziometacarpal joint in 18 patients, 16 women and two men, mean age of 61 years (range 38-74). Six of them had involvement of the scaphotrapezial joint. After a mean follow-up of 8.5 months (range 2-21) one of the patients were completely satisfied with the result of the operation, seven were quite satisfied, and two considered themselves unchanged. None was made worse. Of the 12 patients who did not have involvement of the scaphotrapezial joint nine were completely satisfied and three quite satisfied. Grip strength on the operated side was 75.5% (32%-100%), and pulp pinch was 74.5% (30%-100%) of that in the contralateral one. The mobility of the thumb was influenced little by the operation. Wedge osteotomy of the first metacarpal is a simple and safe way of relieving pain, particularly in the early stages of osteoarthrosis of the basal thumb joint.

Entities:  

Mesh:

Year:  1996        PMID: 8711445     DOI: 10.3109/02844319609072407

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  3 in total

Review 1.  Surgery for thumb (trapeziometacarpal joint) osteoarthritis.

Authors:  Anne Wajon; Toby Vinycomb; Emma Carr; Ian Edmunds; Louise Ada
Journal:  Cochrane Database Syst Rev       Date:  2015-02-23

2.  Surgical treatment of trapeziometacarpal joint osteoarthritis.

Authors:  Giuseppe Taccardo; Rocco DE Vitis; Giuseppe Parrone; Giuseppe Milano; Francesco Fanfani
Journal:  Joints       Date:  2014-01-08

3.  Precision of the Wilson corrective osteotomy of the first metacarpal base using specific planning and instruments for treatment of basal thumb arthritis.

Authors:  Philipp Kriechling; Lisa Reissner; Christoph Zindel; Octavian Andronic; Andreas Schweizer
Journal:  Arch Orthop Trauma Surg       Date:  2022-04-09       Impact factor: 2.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.